[HTML][HTML] Human papillomavirus-related oropharyngeal cancer
High-risk human papillomavirus (HPV) is now recognised as the principal cause of the
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …
increasing incidence rates of oropharyngeal squamous cell carcinoma (OPSCC) in some …
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
Human papillomavirus (HPV) is etiologically responsible for a distinct subset of head and
neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most …
neck squamous cell cancers (HNSCCs). HPV-positive HNSCCs (HPV-HNSCCs) most …
[HTML][HTML] An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer
RO Alabi, A Almangush, M Elmusrati, I Leivo… - International Journal of …, 2022 - Elsevier
Background The optimal management of oropharyngeal squamous cell carcinoma (OPSCC)
includes both surgical and non-surgical, that is,(chemo) radiotherapy treatment options and …
includes both surgical and non-surgical, that is,(chemo) radiotherapy treatment options and …
The “new” head and neck cancer patient—young, nonsmoker, nondrinker, and HPV positive: evaluation
DG Deschler, JD Richmon… - … --Head and Neck …, 2014 - journals.sagepub.com
Objective The near epidemic rise of the incidence of human papillomavirus (HPV)-related
oropharyngeal squamous cell carcinomas (OPSCC) presents the practitioner with a “new” …
oropharyngeal squamous cell carcinomas (OPSCC) presents the practitioner with a “new” …
Development and validation of a radiomic signature to predict HPV (p16) status from standard CT imaging: a multicenter study
RTH Leijenaar, M Bogowicz, A Jochems… - The British journal of …, 2018 - birpublications.org
Objectives: Human papillomavirus (HPV) positive oropharyngeal cancer (oropharyngeal
squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative …
squamous cell carcinoma, OPSCC) is biologically and clinically different from HPV negative …
[HTML][HTML] HPV in oropharyngeal cancer: the basics to know in clinical practice
S Elrefaey, MA Massaro, S Chiocca… - Acta …, 2014 - ncbi.nlm.nih.gov
The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is rising in contrast to
the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of …
the decreasing incidence of carcinomas in other subsites of the head and neck, in spite of …
[HTML][HTML] Human papillomavirus-associated head and neck cancers. Where are we now? A systematic review
M Pinkiewicz, K Dorobisz, T Zatoński - Cancer Management and …, 2022 - ncbi.nlm.nih.gov
Background Human papillomavirus targets the skin and mucous membranes, producing
benign hyperplastic lesions and precancerous and cancerous lesions. An increasing …
benign hyperplastic lesions and precancerous and cancerous lesions. An increasing …
Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer
WR McIlwain, AJ Sood, SA Nguyen… - … Otolaryngology–Head & …, 2014 - jamanetwork.com
Importance This study addresses the most common initial symptoms of oropharyngeal
squamous cell carcinoma (OPSCC) and investigates differences between human …
squamous cell carcinoma (OPSCC) and investigates differences between human …
Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT
BACKGROUND AND PURPOSE: Human papillomavirus–associated oropharyngeal
squamous cell carcinoma is increasing in prevalence and typically occurs in younger …
squamous cell carcinoma is increasing in prevalence and typically occurs in younger …
Clinical variables and magnetic resonance imaging‐based radiomics predict human papillomavirus status of oropharyngeal cancer
P Bos, MWM van den Brekel, ZAR Gouw… - Head & …, 2021 - Wiley Online Library
Background Human papillomavirus (HPV)‐positive oropharyngeal squamous cell
carcinoma (OPSCC) have better prognosis and treatment response compared to HPV …
carcinoma (OPSCC) have better prognosis and treatment response compared to HPV …
